What: A trial demonstrated that semaglutide—a weight loss drug—helped reduce alcohol consumption by 40%, providing early evidence for its potential beyond weight loss.
Key line: [Details not provided].
Source: The Guardian.
What: A trial demonstrated that semaglutide—a weight loss drug—helped reduce alcohol consumption by 40%, providing early evidence for its potential beyond weight loss.
Key line: [Details not provided].
Source: The Guardian.
A study underscores that preventing preeclampsia is key to reducing serious postpartum complications.
A federal judge temporarily halted Trump’s planned deep NIH funding cuts after attorneys general from 22 states sued to block the move.
RFK, Jr. is sworn in as HHS secretary and takes a dig at previous agency messaging while promising “the truth” so mothers can make informed decisions.
An intimate essay describes the overwhelming stress of a high-risk pregnancy designation.
RFK Jr. demonstrated uncertainty over Medicare fundamentals during his nomination hearing.
An analysis of five years of U.S. maternal mortality data reveals significant state-to-state differences in causes of death.
Employers are responding to rising fertility costs by increasing access to preconception care, according to new research.
New York introduces a shield law to protect doctors who prescribe abortion medications.
The debate over rebranding early-stage cancers like DCIS aims to reduce patient anxiety.
Cheryl Wishhover delivers a witty review of celebrity menopause products, questioning their true benefits and efficacy.
A study comparing sisters of women with and without pregnancy complications found that genetic and environmental factors may drive cardiovascular disease risk.
An analysis of emerging investment trends shaping the future of women’s health research.
The Cut’s Beauty Editor examines Botox resistance—a rare phenomenon where antibodies may reduce the effectiveness of neuromodulators like Botox.
A review of over 90,000 drug trials shows that pregnant women are almost entirely excluded.
The New York Times investigates whether testosterone therapy could benefit menopausal women.
Nearly one in four women under age 50 believe that health influencers are as reliable as healthcare providers.
Women voice frustrations over intrusive social media ads during perimenopause.
Chiquita Brooks-LaSure warns that cuts by Elon Musk’s DOGE team could jeopardize health insurance coverage for many American women, affecting both Medicaid and Medicare.
New techniques in managing maternal blood pressure are emerging.
A report highlights confusion over Tennessee’s recent Medicaid expansion for postpartum care.